2026年の記事一覧

• Nakashima I, Ohashi T, Yokoyama K, Kaida K, Nakahara J, Kondo T, Yoshikura N, Shimizu Y, Nohara C, Sakurai K, Yokote H, Niino M, Yamamura T, Fujihara K, Isobe N, Ochi H, Mori M, Kawachi I, Shimizu F, Kanda M, Tani Y, Fukazawa T
  A multicenter, retrospective study in patients with multiple sclerosis treated with natalizumab in a real-world setting in Japan: The REFIND study.
  Mult Scler Relat Disord 2026; 107:107007

• Fujihara K, Isobe N, Miyamoto K, Niino M, Nakahara J, Hattori S, Tanaka M, Tahara M, Suzumura A, Sakurai K, Yoshikura N, Shiomi K, Ochi H, Nagata E, Deguchi K, Tomizawa Y, Yamashita K, Nagatsuka T, Adachi H, Nakashima I
  Long-term effectiveness and safety of satralizumab for neuromyelitis optica spectrum disorder in a real-world clinical setting in Japan: A 2.5-year final analysis of a multicenter medical chart review (The SAkuraBeyond Study).
  Mult Scler 2026; 32:302-314.